The observation that tetrac/nanotetrac can chemosensitize tumor cells previously resistant to agents such as doxorubicin and etoposide [9] caused us to undertake the present review of molecular mechanisms that may be the basis for actions of tetrac/nanotetrac on P-gp. The gene discussed is PGP; the disease is neoplasm.